End of life decisions in immunocompromised patients with acute respiratory failure.
暂无分享,去创建一个
M. Antonelli | J. Rello | S. Jaber | É. Azoulay | A. Kouatchet | F. Taccone | A. De Jong | P. Pickkers | F. Pène | A. Barratt-Due | V. Metaxa | K. Rusinova | D. Mokart | P. Schellongowski | A. Van de Louw | M. Valkonen | P. Bauer | G. Burghi | I. Loeches | M. Soares
[1] M. Golubić,et al. Experiences and attitudes of medical professionals on treatment of end-of-life patients in intensive care units in the Republic of Croatia: a cross-sectional study , 2022, BMC medical ethics.
[2] C. Lory,et al. End of life in the critically ill patient: evaluation of experience of end of life by caregivers (EOLE study) , 2021, Annals of Intensive Care.
[3] H. Wunsch,et al. Critical illness in patients with hematologic malignancy: a population-based cohort study , 2021, Intensive Care Medicine.
[4] C. Sprung,et al. Changes in End-of-Life Practices in European Intensive Care Units From 1999 to 2016. , 2019, JAMA.
[5] D. Angus,et al. ICU staffing feature phenotypes and their relationship with patients’ outcomes: an unsupervised machine learning analysis , 2019, Intensive Care Medicine.
[6] G. Mufti,et al. The role of a critical care outreach service in the management of patients with haematological malignancy , 2019, Journal of the Intensive Care Society.
[7] É. Azoulay,et al. Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data , 2019, Intensive Care Medicine.
[8] É. Azoulay,et al. Acute respiratory failure in immunocompromised adults , 2018, The Lancet Respiratory Medicine.
[9] M. Antonelli,et al. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study , 2017, Intensive Care Medicine.
[10] Thomas J. Smith,et al. The TEAM Approach to Improving Oncology Outcomes by Incorporating Palliative Care in Practice. , 2017, Journal of oncology practice.
[11] J. Vincent,et al. Decision‐Making on Withholding or Withdrawing Life Support in the ICU: A Worldwide Perspective , 2017, Chest.
[12] Priya Ranganathan,et al. Common pitfalls in statistical analysis: Logistic regression , 2017, Perspectives in clinical research.
[13] F. Bozza,et al. Family care, visiting policies, ICU performance, and efficiency in resource use: insights from the ORCHESTRA study , 2017, Intensive Care Medicine.
[14] P. Yates,et al. A systematic review of prognostic factors at the end of life for people with a hematological malignancy , 2017, BMC Cancer.
[15] É. Azoulay,et al. Critical care of patients with cancer , 2016, CA: a cancer journal for clinicians.
[16] A. Meert,et al. Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie (Grrr-OH) study , 2016, Annals of Intensive Care.
[17] D. Angus,et al. Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care Units. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] R. Truog,et al. The DNR Order after 40 Years. , 2016, The New England journal of medicine.
[19] C. Newgard,et al. Missing Data: How to Best Account for What Is Not Known. , 2015, JAMA.
[20] N. Pattison,et al. Negotiating Transitions: Involvement of Critical Care Outreach Teams in End-of-Life Decision Making. , 2015, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[21] J. Curtis,et al. Global variability in withholding and withdrawal of life-sustaining treatment in the intensive care unit: a systematic review , 2015, Intensive Care Medicine.
[22] J. Vincent,et al. The Impact of Hospital and ICU Organizational Factors on Outcome in Critically Ill Patients: Results From the Extended Prevalence of Infection in Intensive Care Study* , 2015, Critical care medicine.
[23] S. Ratcliffe,et al. Variation in decisions to forgo life-sustaining therapies in US ICUs. , 2014, Chest.
[24] T. Similowski,et al. Intensive care unit admission in chronic obstructive pulmonary disease: patient information and the physician’s decision-making process , 2014, Critical Care.
[25] Thomas J. Smith,et al. Early specialty palliative care--translating data in oncology into practice. , 2013, The New England journal of medicine.
[26] E. Roman,et al. Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data , 2011, Palliative medicine.
[27] J. Vincent,et al. Ethics and end-of-life care for adults in the intensive care unit , 2010, The Lancet.
[28] Alona Muzikansky,et al. Early palliative care for patients with metastatic non-small-cell lung cancer. , 2010, The New England journal of medicine.
[29] H. Wunsch,et al. Use of intensive care services during terminal hospitalizations in England and the United States. , 2009, American journal of respiratory and critical care medicine.
[30] Chris Wakefield,et al. Life-supportive therapy withdrawal and length of stay in a large oncologic intensive care unit at the end of life. , 2009, Journal of palliative medicine.
[31] C. Sprung,et al. End-of-life practices in 282 intensive care units: data from the SAPS 3 database , 2009, Intensive Care Medicine.
[32] V. Viallon,et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit* , 2008, Critical care medicine.
[33] S. Chevret,et al. The ICU Trial: A new admission policy for cancer patients requiring mechanical ventilation* , 2007, Critical care medicine.
[34] M. Levy,et al. International differences in end-of-life attitudes in the intensive care unit: results of a survey. , 2005, Archives of internal medicine.
[35] Charles L Sprung,et al. End-of-life practices in European intensive care units: the Ethicus Study. , 2003, JAMA.